Article
Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer
5 May 2022
Abstract excerpt
BACKGROUND: TMPRSS2-ERG gene rearrangement, the most common E26 transformation specific (ETS) gene fusion within prostate cancer, is known to contribute to the pathogenesis of this disease and carries diagnostic annotations for prostate cancer patients clinically. The ERG rearrangement status in prostatic adenocarcinoma currently cannot be reliably identified from histologic features on H&E-stained slides alone...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
